Mark K Buyyounouski, MD, MS

Recent Publications
As Of June, 2008

In Press

D'Ambrosio DJ, Li T., Horwitz EM, Chen DY, Pollack A, Buyyounouski MK. Does Treatment Duration Affect Outcome Following Radiotherapy For Prostate Cancer? Int J Radiat Oncol Biol Phys. 2008 May 7. [Epub ahead of print]

2008

Kaplan DJ, Crispen PL, Greenberg RE, Chen DYT, Viterbo R, Buyyounouski MK, Horwitz EM, Uzzo RG. Residual Prostate Cancer Following Radiotherapy: A Study of Radical Cystoprostatectomy Specimens. Urology. 2008 Feb 19; [Epub ahead of print]

D'Ambrosio DJ, Ruth K, Horwitz E, Chen DJ, Pollack A, Buyyounouski MK. Does Transurethral Resection of Prostate (TURP) affect outcome in patients that subsequently develop prostate cancer? Urology. 2008 Feb 14; [Epub ahead of print]

Eade TN, Ruth K, D’Ambrosio DJ, Feigenberg SJ, Buyyounouski MK, Uzzo RG, Pollack A and Horwitz EM. Comparison of Outcomes in Low Risk Prostate Cancer: I-125 Seed Brachytherapy vs. Intensity Modulated Radiotherapy. Int J Radiat Oncol Biol Phys. 2008 Jan 17; [Epub ahead of print]

2007

D'Ambrosio DJ, Ruth K, Horwitz, EM, Uzzo RG, Pollack A, Buyyounouski MK. How Can Men Destined For Biochemical Failure After Androgen Deprivation And Radiotherapy Be Identified Earlier? Int J Radiat Oncol Biol Phys. 2007 Dec 28; [Epub ahead of print]

Abramowitz MC, Li T, Buyyounouski MK, Ross E, Uzzo RG, Pollack A, Horwitz EM. The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer. Cancer. 2007 Oct 29; [Epub ahead of print].

Williams SG, Buyyounouski MK, Pickles T, Kestin L, Martinez A, Hanlon AL and Duchesne G. The role of the percentage of biopsy cores positive for malignancy in the prediction of prostate cancer radiotherapy outcome is limited: A multicentre analysis of 3264 patients. Int J Radiat Oncol Biol Phys. 2007 Oct 27; [Epub ahead of print]

Buyyounouski MK, Hanlon AL, Horwitz EM, Pollack A. Interval To Biochemical Failure Is Highly Prognostic For Distant Metastasis And Prostate Cancer Specific Mortality Following Radiotherapy. Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):59-66. Epub 2007 Oct 4.

Giri V, Beebe-Dimmer J, Buyyounouski MK, Chen D, Watkins Bruner D, Konski A, Feigenberg SJ, Uzzo RG, Raysor S, Mirchandani I, Gordon R, Cescon T, Godwin A, Weaver J, Hanks G. Prostate Cancer Risk Assessment Program — A Ten-Year Update of Cancer Detection. J Urol. 2007 Sep 12; [Epub ahead of print].

Morgan PB, Hanlon AL, Horwitz EM, Buyyounouski MK, Uzzo RG, Pollack A. Timing of biochemical failure and distant metastatic disease for low-, intermediate-, and high-risk prostate cancer after radiotherapy. Cancer. 2007 Jul 1;110(1):68-80.

Eade TN, Al-Saleem T, Horwitz EM, Buyyounouski MK, Chen DYT, Pollack A. Role of radiotherapy in ductal (endometrioid) carcinoma of the prostate. Cancer. 2007 May 15;109(10):2011-5.

Eade TN, Hanlon AL, Horwitz EM, Buyyounouski MK, Hanks GE, Pollack A. What dose of external-beam radiation is high enough for prostate cancer? Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):682-9. Epub 2007 Mar 29.

D'Ambrosio DJ, Hanlon A, Al-Saleem T, Feigenberg S, Horwitz E, Pollack A, Buyyounouski MK. The Proportion of Prostate Biopsy Tissue with Gleason Pattern 4 Or 5 Predicts for Biochemical And Clinical Outcomes After Radiotherapy For Prostate Cancer. Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1082-7. Epub 2007 Jan 22.

Morgan PB, Hanlon AL, Horwitz EM, Buyyounouski MK, Uzzo RG, Pollack A. Radiation dose and late failures in prostate cancer. Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1074-81. Epub 2006 Dec 29.

2006

Alcantara P, Hanlon A, Buyyounouski MK, Horwitz EM, Pollack A. Prostate-specific antigen nadir within 12 months of prostate cancer radiotherapy predicts metastasis and death. Cancer 2006, 109(1):41-47.

Price RA, Hannoun-Levi JM, Horwitz EM, Buyyounouski M, Ruth KJ, Ma C-M, Pollack. The impact of pelvic nodal irradiation with IMRT on the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 2006, 66(2):583-92.

Pollack A, Hanlon AL, Horwitz EM, Feigenberg SJ, Konski AA, Movsas B, Greenberg RE, Uzzo RG, Ma C-M C, McNeeley SW, Buyyounouski MK, Price RA. Dosimetry and Preliminary Acute Toxicity In The First 100 Men Treated For Prostate Cancer On A Randomized Hypofractionation Dose Escalation Trial. Int J Radiat Oncol Biol Phys 2006, 64:518-26. Epub 2005 Oct 19.

2005

Buyyounouski MK, Hanlon AL, Eisenberg DF, Horwitz EM, Feigenberg SJ, Uzzo RG, Pollack A. Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer. Int J Radiat Oncol Biol Phys 2005, 63(5):1455-62. Epub 2005 Sep 19.

Buyyounouski MK, Hanlon AL, Horwitz EM, Uzzo RG, Pollack A. The Temporal Kinetics of Prostate Specific Antigen (PSA) following 3D-Conformal Radiation Therapy with Androgen Deprivation. Int J Radiat Oncol Biol Phys 2005, 61:1291-1298.

Buyyounouski MK, Klump WJ, Konski A, Wu H, Adler LP. FDG PET Imaging of Signet-Ring Cell Adenocarcinoma of the Stomach. Clin Nucl Med, 2005 Feb, 30:118-119.

2004

Buyyounouski MK, Hanlon AL, Price RA, Feigenberg SJ, Horwitz EM and Pollack A. Defining Erectile Tissue Toxicity. Int J Radiat Oncol Biol Phys 2004, 60:1669.

Buyyounouski MK, Horwitz EM, Hanlon AL, Uzzo RG, Pollack A. Re: Improved Clinical Staging System Combining Biopsy Laterality and TNM Stage for Men With T1c and T2 Prostate Cancer: Results From the Search Database. J. Urol. 2004; 171:1246-1247.

Buyyounouski MK, Horwitz EM, Uzzo RG, Price RA, McNeeley SW, Azizi D, Hanlon AL, Milestone BN, Pollack A. Using MRI-simulation to Define Radiation Dose to the Penile Bulb and Corporal Bodies for Prostate Cancer Patients Treated with Intensity Modulated Radiation Therapy or Iodine-125 Brachytherapy Alone. Int J Radiat Oncol Biol Phys 2004, 59: 1383-1391.

Buyyounouski MK, Horwitz EM, Uzzo RG, Price RA, Hanlon AL, Pollack, A. Intensity Modulated Radiation Therapy To Reduce Doses Received By Erectile Tissues During Prostate Cancer Treatment. Int J Radiat Oncol Biol Phys 2004, 58:743-749.

2003

Buyyounouski MK, Horwitz EM, Hanlon AL, Uzzo RG, Hanks GE, and Pollack, A, Positive Prostate Biopsy Laterality and Implications for Staging. Urology 2003; 62:298- 303.

2002

Kaminski JM, Nguyen K, Buyyounouski M, Pollack A. Prostate cancer gene therapy and the role of radiation. Cancer Treat. Rev. 2002; 28:49-64.

1999

Rubin MA, Buyyounouski M, Baglella E, Sharir S., Neugut A, Benson MC, Katz AE, Olsson CA, Ennis R. Microvessel density in prostate cancer: Lack of correlation with tumor grade, pathological stage and clinical outcome. Urology 1999; 53:542-7.

1997

Hogenboom DL, Kargel JS, Consolmagno CJ, Holden TC, Lee L, Buyyounouski M. The ammonia-water system and the chemical differentiation of icy satellites. Icarus 1997 Jul;128(1):171-180.

Chapters in Edited Books

Pollack A, Eade TM, Horwitz EM, Buyyounouski MK, Hanks GE. In reply to drs. Schultz and kagan. Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1288-9. [Letter to the Editor]

Pollack A, Eade TN, Hanlon AL, Horwitz EM, Buyyounouski MK, Hanks GE. In Reply to Drs. Cheung and Schulz and Kagan. Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):645-646. [Letter to the Editor]

Buyyounouski MK. Comment on influence of local tumor control as assessed by post-treatment prostate biopsies after external beam radiotherapy for prostate cancer on distant metastases and cancer related mortality. J Urol. 2008 Feb 18. [Invited Editorial]

Loehrer P, Ahlering T, Buyyounouski MK. Testicular Cancer. In: Cancer Management: A Multidisciplinary Approach, 10th Ed. R Pazdur, L Coia, L Wagman, W Hoskins (eds.), PRR Treatment Handbook. PRR, Huntington, NY, 2008. [Book Chapter, In Press]

Buyyounouski MK, Horwitz, EH, Pollack A. Prostate. In: Handbook of Radiation Oncology. BG Haffty, LD Wilson (eds.), Jones and Bartlett. (In Press).

Buyyounouski MK, Horwitz EM, Price Jr RA, Feigenberg SJ and Pollack A. Prostate IMRT. In IMRT Handbook: Concepts & Clinical Applications. Bortfeld T, Rupert Schmidt-Ullrich R, de Neve W, Wazer DE (Eds). Springer-Verlag Heidelberg, Germany, 2006.

Buyyounouski MK and Pollack A. External Beam Radiation Therapy for Prostate Cancer. In Atlas of the Prostate; 3rd Ed. Current Medicine LLC, Philadelphia, USA, 2006.

Buyyounouski MK, Hanlon AL, Price RA, Horwitz EM, Feigenberg SJ, Pollack A. In regard to Selek et al. erectile dysfunction and radiation dose to penile base structures: a lack of correlation. IJROBP 2004;59:1039-1046. Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1664-5; author reply 1666. [Letter to the Editor]

Buyyounouski MK, Horwitz EM, Hanlon AL, Uzzo RG, Pollack A. Re: improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the search database. J Urol. 2004 Mar;171(3):1246-7; author reply 1247. [Letter to the Editor]

Abstracts

Buyyounouski MK, Li T, Al-Saleem T, Horwitz E, S. Feigenberg, R. Uzzo, R. Greenberg, Pollack A. Predicting Local Persistenc eof Intermediate and High-risk prostate cancer using percentage of adenocarcinoma in pretreatment biopsy tissue. IJROBP (ASTRO 2008)

Silverman JS, Ruth K, Horwitz EM, Pollack A, Chen DYT, Buyyounouski MK. Radiotherapy for high-risk prostate cancer: have patients 70 years or older benefited from combined androgen deprivation therapy? (ASTRO 2008)

Richardson T, Stoyanova R, Buyyounouski MK. Prostate Spectroscopy in Radiation Therapy: The Role of the Technologist beyond MRI Simulation. Proceedings of the 16th Scientific Meeting of the The International Society for Magnetic Resonance in Medicine, Toronto, Canada, May 3-9, 2008.

Yu JQ, Feigenberg SJ, Eade T, Wang L, Paskalev K, Konski A, Buyyounouski MK, Movsas B, Dadparvar S. FDG PET Response Following Stereotactic Body Radiotherapy for Lung Cancer: Early Results from a Prospective Series. Clinical Nuclear Medicine Vol 33 Number 1 Jan 2008 p78 abstract 13.

Buyyounouski MK, Li T, Al-Saleem T, Horwitz E, Pollack A. Predicting local persistence of prostate cancer using percentage of adenocarcinoma in pretreatment biopsy tissue. The Genitourinary Cancers Symposium, San Francisco, California, February 14 – 16, 2008.

Michalski JM, Lawton, CA, El Naqa IM, Buyyounouski MK, Lee WR, Menard C, O'Meara I, Rosenthal SA, Ritter M, Seider MJ. RTOG GU radiation oncology specialists reach consensus on prostatic fossa clinical target volume for radiation therapy following radical prostatectomy. The Genitourinary Cancers Symposium, San Francisco, California, February 14 – 16, 2008.

Lawton, Michalski JM, CA, El Naqa IM, Buyyounouski MK, Lee WR, Menard C, O'Meara I, Rosenthal SA, Ritter M, Seider MJ. RTOG Genitourinary radiation oncology specialists reach consensus on pelvic lymph node volumes for high risk prostate cancer. The Genitourinary Cancers Symposium, San Francisco, California, February 14 – 16, 2008.

Buyyounouski MK, Li T, Watkins-Bruner D, Horwitz EM, Pollack A. A Comparison Of Sexual Function Following Radiotherapy For Prostate Cancer: Results Of A Prospective, Randomized Trial Of Hypofractionated Intensity Modulated Radiotherapy. Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):S7-S8.

Sharma NK, Li T, Horwitz EM, Pollack A, Buyyounouski MK. Intensity Modulated Radiation Therapy Reduces Gastrointestinal Morbidity in Patients Treated with Androgen Deprivation Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2007 Nov 1;S10.

D'Ambrosio DJ, Li T., Horwitz EM, Chen DY, Pollack A, Buyyounouski MK. Does Total Treatment Duration Affect Outcome in Prostate Cancer treated with Radiotherapy? Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):S176.

Chen Y, Paskalev K, Horwitz E, Price R, Buyyounouski M, Ma C, Pollack A. Effect of Target Smoothness on Treatment Planning for Prostate IMRT. Int J Radiat Oncol Bio Phys. 2007 Nov 1;69(3):S649

Feigenberg S, Yu JQM, Eade TN, Buyyounouski M, Wang L, Langer C, Scott W, Konski A and Movsas B. FDG PET Response by 3 Months Following Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer May be an Early Surrogate of Local Failure. Int J Radiat Oncol Bio Phys. 2007 Nov 1;69(3):S479-S480.

Morgan PB, Ruth K, Horwitz EM, Buyyounouski MK, Uzzo RG and Pollack A. A Matched Pair Comparison of Intensity Modulated Radiotherapy and Three-dimensional Conformal Radiotherapy for Prostate Cancer: Toxicity and Outcomes. Int J Radiat Oncol Bio Phys. 2007 Nov 1;69(3):S319.

Li J, Pollack A, Horwitz E, Buyyounouski M, Price JR R and Ma C. Clinical Experience on Localization and Real-Time Tracking of the Prostate During External Radiotherapy using Calypso® 4D Localization System. Int J Radiat Oncol Bio Phys. 2007 Nov 1;69(3):S189.

Feigenberg SJ, Yu JQ, Eade T, Buyyounouski M, Wang L, Langer C, Scott W, Movsas B. PET response following stereotactic body radiotherapy for non-small cell lung carcinoma correlates with local control. JCO 2007 June 20;25(18S): 18013

Li J, Horwitz E, Buyyounouski M, McNeeley S, Crawford K, Ma C. Do stranded seeds improve the quality of permanent prostate seed implant? Medical Physics. 2007 Jun;34(6):2330-2330.

Paskalev K, Horwitz E, Price R, Feigenberg S, Buyyounouski M, Chen Y, Konski A, Silverman I, Ma C, Pollack A. Daily localization for prostate bed patients based on surgical clips. Medical Physics. 2007 Jun;34(6):2381-2382.

Wang L, Jin L, Hayes S, Paskalev K, Buyyounouski M, Feigenberg S. Dosimetric comparison of 4D and 3 multi-phase CT imaging for stereotactic body radiation therapy (SBRT) planning in lung cancer. Medical Physics. 2007 Jun;34(6):2384-2384.

Chen Y, Paskalev K, Horwitz E, Price R, Buyyounouski M, Ma C, Pollack A . Surface smoothing of a tubular structure using a non-shrinking algorithm Medical Physics. 2007 Jun;34(6):2637-2637.

Morgan PB, Hanlon AL, Horwitz EM, Buyyounouski MK, Uzzo RG and Pollack A. Timing of Biochemical Failure and Distant Metastasis for Low, Intermediate, and High Risk Prostate Cancer after Radiotherapy. Proceedings of the 89th Annual Meeting of the American Radium Society, Hotel Arts, Amsterdam, Netherlands. May 5 to May 9, 2007.

Eade TN, Ruth K, D’Ambrosio DJ, Feigenberg SJ, Buyyounouski MK, Uzzo RG, Pollack A and Horwitz EM. Comparison of Outcomes in Low Risk Prostate Cancer: I-125 Seed Brachytherapy vs. Intensity Modulated Radiotherapy Int J Radiat Oncol Biol Phys. 2006 Nov;66(3):S60-S61.

McNeeley S, Paskalev K, Buyyounouski M, Ma C. Daily changes in seminal vesicle location during treatment of prostate carcinoma Medical Physics. 2006 Jun;33(6):2030-2030.

Morgan PB, Hanlon AL, Horwitz EM, Buyyounouski MK, Uzzo RG and Pollack A. 17: Increasing Radiotherapy Dose for Prostate Cancer Reduces a Late Wave of Distant Metastasis. Int J Radiat Oncol Biol Phys. 2006 Nov;66(3):S9-10.

Eade TN, Ruth K, D'Ambrosio DJ, Feigenberg SJ, Buyyounouski MK, Uzzo RG, Pollack A and Horwitz EM. 106: Comparison of Outcomes in Low Risk Prostate Cancer: I-125 Seed Brachytherapy vs. Intensity Modulated Radiotherapy. Int J Radiat Oncol Biol Phys. 2006 Nov;66(3):S60-S61.

Buyyounouski MK, Hanlon AL, Horwitz EM and Pollack A. 1132: The Prostate Specific Antigen Velocity Is Unaltered by Radiotherapy Alone When 2 ng/mL per Year or Greater: Distant Metastasis Are the Cause. Int J Radiat Oncol Biol Phys. 2006 Nov;66(3):S206-S207.

Abramowitz MC, Li T, Ross E, Buyyounouski M, Uzzo RG, Pollack A and Horwitz EM. 1133: The Nadir+2 Definition of Biochemical Failure Predicts for Overall Survival. Int J Radiat Oncol Biol Phys. 2006 Nov;66(3):Pages S207-S208.

Pahlajani NH, Ruth K, Horwitz EM, Buyyounouski MK, Chen DY and Pollack A. 2194: Smoking and its Relationship to GU and GI Toxicity in Prostate Cancer Patients Treated With Radiation. Int J Radiat Oncol Biol Phys. 2006 Nov;66(3):S317.

Kirichenko AV, Ruth K, Horwitz EM, Buyyounouski MK, Feigenberg SJ, Chen DY and Pollack A. 2209: Intensity Modulated Radiation Therapy for Prostate Cancer: Preliminary Results on Treatment Morbidity Compared to 3-D Conformal Radiation Therapy. Int J Radiat Oncol Biol Phys. 2006 Nov;66(3):S326.

D'Ambrosio DJ, Ruth K, Buyyounouski MK, Horwitz EM, Uzzo RG and Pollack A. 2224: Prostate Specific Antigen Kinetics in Men Treated With Radiotherapy and Androgen Deprivation. Int J Radiat Oncol Biol Phys. 2006 Nov;66(3):S334.

Hanlon AL, Horwitz EM, Buyyounouski MK and Pollack A. 2244: Adjusted Radiotherapy Dose Response Curves Following Treatment for Prostate Cancer: Biochemical Failure And Distant Metastasis. Int J Radiat Oncol Biol Phys. 2006 Nov;66(3):S346-S347.

Sharma NK, Ruth K, Horwitz E, Buyyounouski M and Pollack A. 2281: Statin Use Prior to Radiation Therapy for Prostate Cancer Does Not Improve Outcome: The Fox Chase Experience. Int J Radiat Oncol Biol Phys. 2006 Nov;66(3): S366.

Buyyounouski MK, Hanlon AL, Horwitz EM and Pollack A. The Percentage of Positive Cores Is Not an Appropriate Risk Factor for Prostate Radiotherapy to >=72 Gy. Int J Radiat Oncol Biol Phys. 2005 Oct;63:S200.

D'Ambrosio DJ, Buyyounouski MK, Horwitz EM, Feigenberg SJ, Ruth K and Pollack A. Men with Intermediate Risk Prostate Cancer with a History of Transurethral Resection of Prostate (TURP) have a Higher Risk of Biochemical Failure. Int J Radiat Oncol Biol Phys. 2005 Oct;63:S311.

Buyyounouski MK, Hanlon AL, Horwitz EM, Feigenberg SF, Pollack, A. The Houston Definition for Biochemical Failure as an Early Predictor for Distant Metastasis and Mortality. Proceedings of the 87th Annual Meeting of the American Radium Society, Hotel Arts, Barcelona, Spain. April 30 to May 4, 2005.

D'Ambrosio D, Hanlon A, Al-Saleem T, Feigenberg S, Horwitz E, Alan Pollack, Buyyounouski MK. The Proportion of Prostate Biopsy Tissue with Gleason Pattern 4 Or 5 Predicts for Biochemical And Clinical Outcomes After Radiotherapy For Prostate Cancer. Proceedings of the 87th Annual Meeting of the American Radium Society, Hotel Arts, Barcelona, Spain. April 30 to May 4, 2005.

Buyyounouski MK, Hanlon AL, Horwitz EM, Al-Saleem T, Pollack, A. Pretreatment Risk Stratification of Prostate Cancer with Percent Positive Prostate Biopsy Tissue Obviates the Need for Clinical Staging and Identifies High Grade Disease suitable for Treatment without Androgen Deprivation. Int J Radiat Oncol Biol Phys. 2004 Sept;60(1):S433.

Buyyounouski MK, Hanlon AL, Horwitz EM, Pollack, A. Defining Biochemical Failure after Radiation therapy with and without Androgen Deprivation for Prostate Cancer. The 86th Annual Meeting of the American Radium Society, May 1-5, 2004. Silverado Resort & Country Club, Napa Valley, California.

Buyyounouski MK, Hanlon AL, Pollack A. The Temporal Kinetics of Prostate Specific Antigen (PSA) following 3D-Conformal Radiation Therapy with Androgen Deprivation. Int J Radiat Oncol Biol Phys. 2003 Oct;57(2):S147-8.

Buyyounouski MK, Horwitz EM, Price R, Hanlon AL, Uzzo RG, Pollack A. Intensity Modulated Radiation Therapy To Reduce Dose To Erectile Tissue During Prostate Cancer Treatment. The 85th Annual Meeting of the American Radium Society, April 27-30, 2003, Houston, Texas: Cancer Journal 2003; 9: 485-519.

Horwitz EM, Buyyounouski MK, Uzzo RG, Price RA, McNeeley SW, Azizi D, Hanlon AL, Milestone BN, Pollack A. Using MRI-simulation to Define Radiation Dose to the Penile Bulb and Corporal Bodies for Prostate Cancer Patients Treated with Intensity Modulated Radiation Therapy or Iodine-125 Brachytherapy Alone. The 85th Annual Meeting of the American Radium Society. Houston, Texas, April 27-30, 2003.

Buyyounouski MK, Horwitz EM, Hanlon AL, Uzzo RG, Hanks GE, Pollack A. The use of prostate biopsy laterality results in localized prostate cancer does not predict for 7-yr bNED outcome. Int J Radiat Oncol Biol Phys. 2002 Oct;54(2):S264-265.

McNeeley S, Buyyounouski M, Price R, Horwitz E, Ma C. Prostate Displacement During Transabdominal Ultrasound. The 44th annual meeting of the AAPM. Medical Physics 2002;29(6):1341-1341.

Rubin MA, Buyyounouski M, Katz AE, Olsson CA, Ennis RD. Microvessel density in prostate cancer: Lack of correlation with tumor grade, pathologic stage, and clinical outcome. Modern Pathology 11 (1): 94A-94A JAN 1998

Hogenboom DL, Kargel, JS, Holden TC, Buyyounouski M. The phase diagram of ammonia monohydrate; a new high-pressure polymorph. Abstracts of papers submitted to the Twenty-sixth lunar and planetary science conference. 1995, 26: 613-614.

Radiation Oncology

Attending Physician

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111-2497

To make an appointment, call:
215-728-3815.

For general information, call:
1-888-FOX CHASE.
An oncology certified nurse will assist you.

Back to
Dr. Buyyounouski's Directory Page